Literature DB >> 25847084

Gender-specific effects of CGP 55845, GABAB receptor antagonist, on neuromuscular coordination, learning and memory formation in albino mouse following neonatal hypoxia-ischemia insult.

Quratul Ane Gillani1, Atif Akbar, Muhammad Ali, Furhan Iqbal.   

Abstract

GABAB receptor antagonists are experimentally proved as spatial memory enhancers in mouse models but their role has not been described following hypoxic-ischemic insult. 10-day-old albino mice were subjected to Murine model of hypoxia and ischemia. Following brain damage, mice were fed on normal rodent diet till they were 13 weeks old. At this time point, mice were divided into two groups. Group 1 received saline and group 2 received intraperitoneally CGP 55845 (1 mg/ml solvent/Kg body weight) for 12 days. Behavioural observations were made during rota rod, open field and Morris water maze test along with brain infarct measurement in both CGP 55845 treated and untreated groups. It was observed that application of GABAB receptor antagonist improved the over all motor function in male and female albino mice but effects were more pronounced in males. In open field, CGP 55845-treated female mice showed poor performance. CGP 55845 had no significant effect on learning and memory formation during Morris water maze test and also on brain infract size in both genders following hypoxia ischemia encephalopathy. Effects of CGP 55845 can be further explored in a dose and duration dependent manner to improve the learning and memory in albino mice following neonatal brain damage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25847084     DOI: 10.1007/s10072-015-2205-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS.

Authors:  U Stäubli; J Scafidi; D Chun
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Pre- and postsynaptic GABAB receptors in the hippocampus have different pharmacological properties.

Authors:  P Dutar; R A Nicoll
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

3.  Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus.

Authors:  E W Daenen; J A Van der Heyden; C G Kruse; G Wolterink; J M Van Ree
Journal:  Brain Res       Date:  2001-11-09       Impact factor: 3.252

4.  Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Mehrdad Faizi; Lucia F Jacobs; Khin Htun; Mehrdad Shamloo; William C Mobley
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

5.  GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats.

Authors:  K Heese; U Otten; P Mathivet; M Raiteri; C Marescaux; R Bernasconi
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

6.  Effects of dietary creatine supplementation for 8 weeks on neuromuscular coordination and learning in male albino mouse following neonatal hypoxic ischemic insult.

Authors:  Shahid Iqbal; Muhammad Ali; Atif Akbar; Furhan Iqbal
Journal:  Neurol Sci       Date:  2014-12-16       Impact factor: 3.307

7.  Constitutive NF-kappa B activity in neurons.

Authors:  C Kaltschmidt; B Kaltschmidt; H Neumann; H Wekerle; P A Baeuerle
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Differential ontogenesis of presynaptic and postsynaptic GABAB inhibition in rat somatosensory cortex.

Authors:  A Fukuda; I Mody; D A Prince
Journal:  J Neurophysiol       Date:  1993-07       Impact factor: 2.714

9.  Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy.

Authors:  D J Stuckey; D C Anthony; J P Lowe; J Miller; W M Palm; P Styles; V H Perry; A M Blamire; N R Sibson
Journal:  J Leukoc Biol       Date:  2005-05-20       Impact factor: 4.962

10.  CGP 35348, GABA B receptor antagonist, has a potential to improve neuromuscular coordination and spatial learning in albino mouse following neonatal brain damage.

Authors:  Q Gillani; M Ali; F Iqbal
Journal:  Biomed Res Int       Date:  2014-04-06       Impact factor: 3.411

View more
  6 in total

1.  Sex difference in the contribution of GABAB receptors to tibial neuromodulation of bladder overactivity in cats.

Authors:  Thomas W Fuller; Xuewen Jiang; Utsav Bansal; Vladimir Lamm; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-14       Impact factor: 3.619

Review 2.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 3.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

4.  Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus.

Authors:  Xiao-Jun Cai; Lei Wang; Chun-Mei Hu
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

Review 5.  Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges.

Authors:  Lancelot J Millar; Lei Shi; Anna Hoerder-Suabedissen; Zoltán Molnár
Journal:  Front Cell Neurosci       Date:  2017-05-08       Impact factor: 5.505

Review 6.  The Roles of GABA in Ischemia-Reperfusion Injury in the Central Nervous System and Peripheral Organs.

Authors:  Chaoran Chen; Xiang Zhou; Jialiang He; Zhenxing Xie; Shufang Xia; Guangli Lu
Journal:  Oxid Med Cell Longev       Date:  2019-11-11       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.